We provide consulting services in the field of solid state research, crystallization, particle technology and pharmaceutical development:

  • Data review and strategic guidance
  • Preparation of Request for Proposals
  • Selecting suitable CRO/CDMO and overseeing projects, e.g.
    • polymorph, salt, cocrystal, and amorphous dispersion screening
    • preformulation and formulation development
    • physicochemical testing of drug substance and drug products
    • solid state and particle size method development and validation
    • experimental design for crystallization process development for purification, polymorph and/or particle size control
    • de-risking and troubleshooting of drug substance and drug product processes
    • scientific review of project updates and reports
  • Defining API needs and supporting drug product development activities
  • Analytical support for solid state, particle & PAT techniques
  • Preparation of summary reports or presentations
  • Regulatory guidance associated with solid forms and particle characteristics
  • Technical writing for relevant sections of IND and NDA
  • Strategic guidance for intellectual property protection
  • Scientific review of patents